Cargando…
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
Ginseng has been used for the treatment of aging and memory impairment for thousands of years. Several studies have found that ginsenoside Rg1, as one of the main active components of ginseng, could potentially improve cognitive function in several different animal models. A preclinical systematic r...
Autores principales: | Liang, Hai-Yong, Zhang, Pei-Pei, Zhang, Xi-Le, Zheng, Yan-Yan, Huang, Yan-Ran, Zheng, Guo-Qing, Lin, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993717/ https://www.ncbi.nlm.nih.gov/pubmed/33686024 http://dx.doi.org/10.18632/aging.202619 |
Ejemplares similares
-
A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease
por: Song, Liang, et al.
Publicado: (2017) -
Pharmacological activities of ginsenoside Rg5 (Review)
por: Liu, Ming-Yang, et al.
Publicado: (2021) -
Extracts or Active Components from Acorus gramineus Aiton for Cognitive Function Impairment: Preclinical Evidence and Possible Mechanisms
por: Li, Yan, et al.
Publicado: (2020) -
Ginsenoside Rg1 improves cognitive capability and affects the microbiota of large intestine of tree shrew model for Alzheimer's disease
por: Guo, Yuqian, et al.
Publicado: (2021) -
Comment on “A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease”
por: He, Yi-bo, et al.
Publicado: (2017)